The University of Adelaide has created a free, 5-week online course that explains the biological basis of chronic drug use and addiction and describes treatment options such as pharmacotherapy, psychosocial interventions, and life skills. The course, which begins October 8, 2015, is designed for health care professionals and policymakers, particularly those in low- or middle-income countries. More information is available here.
Former NIDA International fellows and their international partners have published findings from research funded through RFA-DA-10-008, International Research Collaborations on HIV/AIDS and Drug Use. The funding opportunity was issued to stimulate collaborative research among foreign investigators from the same geographic regions to address regional issues on the intersection of HIV/AIDS and drug use in international settings. The articles include:
Perrine Roux, Pharm.D., Ph.D., French National Institute of Health and Medical Research (Inserm), has been selected as a NIDA INVEST Drug Abuse Research Fellow. She will work with Sandra D. Comer, Ph.D., Columbia University, to better define the concept of nonadherence to opioid maintenance treatment with buprenorphine/naloxone and to validate a tool to measure nonadherence using a self-administered questionnaire.
The governments of Tanzania and the United States have announced that the first medication- assisted therapy (MAT) program for drug users in sub-Saharan Africa will begin shortly at two sites in Dar es Salaam and one in Zanzibar. Recognizing that high-risk practices related to drug use contribute to HIV transmission, the Tanzania Drug Control Commission (DCC) has promoted and adopted novel and evidence-based interventions to facilitate improved access to services that prevent HIV among drug users.